• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 2009

View Archived Issues

Phase II data show that citalopram has similar effects to antipsychotics in AD patients

Read More

Safety and efficacy of memantine in Alzheimer's disease reported at ICAD

Read More

Lymphotoxin-alpha targeting antibody S5H3 inhibits autoimmune disease in mice

Read More

Labeled polypeptides for the diagnosis of fibrosis described by INSERM

Read More

Roche claims non-nucleoside reverse transcriptase inhibitors for the treatment of HIV and AIDS

Read More

Tubulin polymerization inhibitors for cancer therapy disclosed by Universita degli studi di Milano

Read More

Glenmark Pharmaceuticals presents VR1 receptor antagonists for the treatment of pain

Read More

Bayer Schering Pharma claims HNE inhibitors for pulmonary hypertension, COPD, etc.

Read More

Ariad presents preliminary data from two ongoing ridaforolimus trials in cancer

Read More

CSL begins shipment of influenza virus vaccine for 2009-2010 flu season

Read More

FDA accepts CyDex's IND for phase IIa study of CDX-353 in multiple myeloma

Read More

RXi acquires exclusive worldwide license to Advirna's RNAi delivery technology

Read More

BrainCells reports results from a clinical proof-of-concept study of BCI-952 in MDD

Read More

FDA issues EUA for Focus Diagnostics' influenza H1N1 virus test

Read More

Phytopharm and CHDI sign agreement to evaluate Cogane in preclinical model of HD

Read More

Asenapine meets primary endpoint in long-term extension study in schizophrenia

Read More

Dirucotide does not meet primary endpoint in phase III MAESTRO-01 trial in MS

Read More

Amgen to collaborate with GSK to commercialize denosumab in Europe

Read More

Biofrontera reports efficacy data for BF-derm1 in severe chronic urticaria

Read More

Acceleron and Celgene begin phase II ACE-011 study for chemotherapy-induced anemia

Read More

Sanofi launches Multaq in the U.S. for atrial fibrillation or atrial flutter

Read More

Novartis launches Clozaril for treatment-resistant schizophrenia in Japan

Read More

Takeda submits NDA in Japan for fixed-dose combination of pioglitazone and glimepiride

Read More

ELND-005 displays safety and favorable pharmacokinetics in humans and rodents

Read More

CG3R6TAT nanoparticles cross blood-brain barrier, show enhanced antimicrobial activity

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe